Abstract:Background: In this study, we aimed to explore the mechanism by which resveratrol promotes cisplatin-induced death of HepG2 cells and to provide a potential strategy for resveratrol in the treatment of cancer. Methods: HepG2 cells were exposed to a range of drug concentrations for 24 h: resveratrol (2.5 μg/mL [10.95 μM], 5 μg/mL [21.91 μM], 10 μg/mL [43.81 μM], 20 μg/mL [87.62 μM], 40 μg/mL [175.25 μM], and 80 μg/mL [350.50 μM]), cisplatin (0.625 μg/mL [2.08 μM], 1.25 μg/mL [4.17 μM], 2.5 μg/mL [8.33 μM], 4.5 μg/mL [15.00 μM], and 10 μg/mL [33.33 μM]), 24 μg/mL (105.15 μM) resveratrol + 9 μg/mL (30.00 μM) cisplatin, and 12 μg/mL (52.57 μM) resveratrol + 4.5 μg/mL (15.00 μM) cisplatin. The interaction of two drugs was evaluated by coefficient of drug interaction (CDI), which was based on the Pharmacological Additivity model. The MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to detect the effect of different concentrations of drugs on cell viability, while transcriptome sequencing was used to identify pathways associated with higher gene enrichment. Synchrotron radiation FTIR microspectroscopy experiments and data analysis were conducted to obtain detailed spectral information. The second-derivative spectra were calculated using the Savitzky–Golay algorithm. Single-cell infrared spectral absorption matrices were constructed to analyze the spectral characteristics of individual cells. The Euclidean distance between cells was calculated to assess their spectral similarity. The cell-to-cell Euclidean distance was computed to evaluate the spatial relationships between cells. The target protein of resveratrol was verified by performing a Western blot analysis. Results: After 24 h of treatment with resveratrol, HepG2 cell growth was inhibited in a dose-dependent manner. Resveratrol promotes cisplatin-induced HepG2 cell death through membrane-related pathways. It also significantly changes the membrane components of HepG2 cells. Additionally, resveratrol changes the morphology of the HepG2 cell membrane by decreasing the expression of PLA2G2. Conclusion: Resveratrol changes the morphology of the HepG2 cell membrane by decreasing the expression of PLA2G2 and promotes cisplatin-induced HepG2 cell death. The combination of cisplatin and resveratrol can play a synergistic therapeutic effect on HepG2 cells.

Preliminary studies on effects of resveratrol in inhibiting growth of HepG2 and inducing its apoptosis

Apoptosis of Implanted Tumor of Human Primary Gastric Cancer Cells in Nude Mice Induced by Resveratrol

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

Resveratrol Induced Apoptosis and Cell Arrest in Cancer Cells

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

Resveratrol Inhibits VEGF Expression of Human Hepatocellular Carcinoma Cells Through a NF-kappa B-mediated Mechanism.

Effects of Resveratrol on Matrix Metalloproteinase-9 Expression in Hepatoma Cells

Effect of resveratrol derived from Rhizoma polygoni cuspidati on growth and proliferation of hepatocellular carcinoma H22 of Mouse

Effects of resveratrol on cell cycle regulatory processes of human lung adenocarcinoma A549 cells and its mechanism

Effects of Resveratrol on the Proliferation, Apoptosis and Telomerase Ability of Human A431 Epidermoid Carcinoma Cells.

Study on the resveratrol induced apoptosis in hunman cervical cancer cell line HeLa

Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Effect of resveratrol on inducing proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells

Effect of Resveratrol on Proliferation and Apoptosis of Human Cervical Cancer Cell Line SiHa

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Effect of resveratrol on the proliferation and apoptosis of melanoma cell line A375 cells

Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin.

Resveratrol Induces Apoptosis and Cell Cycle Arrest of Human T24 Bladder Cancer Cells in Vitro and Inhibits Tumor Growth in Vivo

In Vitro and in Vivo Evaluation of the Antitumor Efficiency of Resveratrol Against Lung Cancer

Resveratrol Induced Apoptosis in Human Gastric Carcinoma SGC‐7901 Cells Via Activation of Mitochondrial Pathway